Medical Equipment

Global Epigenetics Market Anticipated To Grow To $35 Billion By 2030 At 22.3% CAGR

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Epigenetics Market Through 2030?

The epigenetics market has experienced rapid expansion in recent years. It is projected to grow from $12.74 billion in 2025 to $15.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.6%. This historical growth can be credited to factors such as increasing cancer research activities, the expansion of academic genomics research, the availability of advanced sequencing instruments, a growing emphasis on molecular diagnostics, and rising funding for life sciences research.

The epigenetics market is poised for significant expansion in the coming years. Projections indicate it will reach a value of $35.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This anticipated growth throughout the forecast period stems from factors such as increased investments in precision medicine, the growing acceptance of epigenetic therapeutics, the broader application of personalized oncology treatments, the expanding utilization of AI-driven genomic analysis, and enhanced collaborations between pharmaceutical companies and research institutions. Key trends anticipated during this period encompass the escalating use of epigenetic biomarkers in oncology, a greater uptake of high-throughput epigenetic analysis tools, the increasing need for DNA methylation assays, the broadening scope of epigenetics-based drug discovery initiatives, and improved integration of bioinformatics platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Major Factors Are Contributing To The Development Of The Epigenetics Market?

The epigenetics market is anticipated to expand due to a growing emphasis on precision medicine in the future. This medical strategy tailors treatment to individual requirements by examining genetic, environmental, and lifestyle data. Within epigenetics, precision medicine leverages personalized epigenetic profiles and genetic information to develop customized healthcare plans, leading to more effective disease management and patient treatment. For example, Novotech, an Australia-based biotechnology firm, reported in March 2024 that in 2023, out of 217 FDA-approved oncology treatments, 43% were precision oncology therapies, with 78 of these featuring DNA or NGS-detectable biomarkers. Consequently, the heightened focus on precision medicine is fueling the expansion of the epigenetics market.

Which Segment-Based Categories Are Covered In The Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Trends Are Guiding The Development Of The Epigenetics Market?

Leading companies operating within the epigenetics market are increasingly prioritizing the adoption of artificial intelligence (AI)-driven analytics to secure a competitive advantage. AI-driven analytics is defined as the utilization of artificial intelligence (AI) technologies to automatically process and comprehend vast quantities of data. For instance, in July 2023, FOXO Technologies, a US-based firm, introduced Bioinformatics Services, designed to revolutionize epigenetic data analysis. FOXO’s Bioinformatics Services deliver a flexible platform of cutting-edge data solutions, specifically tailored to cater to the unique demands of clients across academia, healthcare, and pharmaceutical research. Utilizing an innovative array of bioinformatic tools, FOXO’s objective is to equip its clients to enhance the speed and accuracy with which they handle, analyze, and interpret data sets, thereby accelerating new discoveries and fostering a greater comprehension of complex diseases.

Who Are The Major Companies Operating In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Access The Complete Epigenetics Market Report:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Region Holds The Largest Share In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Epigenetics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795